Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 4 boards, counting each seat separately. Longest: Atara Biotherapeutics Inc., 2 years.
Atara Biotherapeutics Inc.
Director
Zymeworks Inc.
Director
REGENXBIO Inc.
Director
Gossamer Bio Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Atara Biotherapeutics Inc. June 10, 202598.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 27, 2026 | REGENXBIO Inc. | Open-market purchase | +53,407 | $9.36 | $499,676 |
| Aug 26, 2026 | REGENXBIO Inc. | Open-market purchase | +49,196 | $9.14 | $449,706 |
| Aug 25, 2026 | REGENXBIO Inc. | Grant or award | +15,432 | — | — |
| Jun 9, 2026 | Atara Biotherapeutics Inc. | Grant or award | +12,000 | — | — |
| Aug 12, 2025 | Zymeworks Inc. | Grant or award | +415,000 | $12.02 | $4,988,300 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.